424 Capital-backed BroadcastMed completed the acquisition of Harborside.

424 Capital-backed BroadcastMed, a healthcare media company, completed the acquisition of Harborside, a medical communications company. Financial terms were not disclosed. "Our acquisition of Harborside will help advance the field of oncology communications to greater heights. BroadcastMed is committed to using our industry-leading media solutions to improve the ways in which specialty-centric clinicians share their subject matter expertise," Ross Joel, BroadcastMed CEO.